Home → Resource → Jimenez JL, Tighiouart M, Gasparini M (2018) Cancer phase I trial design using drug combinations when a fraction of dose limiting toxicities is attributable to one or more agents, Biometrical Journal

Jimenez JL, Tighiouart M, Gasparini M (2018) Cancer phase I trial design using drug combinations when a fraction of dose limiting toxicities is attributable to one or more agents, Biometrical Journal

https://doi.org/10.1002/bimj.201700166

website

EU Funding
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 633567.
©2015 Lancaster University